Erschienen in:
25.10.2017 | What's New in Intensive Care
Adjuvant therapies in critical care: steroids in community-acquired pneumonia
verfasst von:
Antoni Torres, Miquel Ferrer, Michael S. Niederman
Erschienen in:
Intensive Care Medicine
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Excerpt
Severe community-acquired pneumonia (CAP) is present in up to 19% of hospitalized patients with CAP and still carries a high morbidity and mortality. A French multicentre study of severe pneumococcal CAP patients admitted to intensive care units (ICU) reported an overall mortality rate of 29% [
1]. The high mortality of severe CAP occurs despite the fact that the majority of patients receive an early and adequate antibiotic treatment. This is probably due, in part, to an imbalanced and disproportionate local and systemic inflammatory response that contributes to impairment of gas exchange, sepsis and end-organ dysfunction. …